1. Home
  2. QLGN vs TAOP Comparison

QLGN vs TAOP Comparison

Compare QLGN & TAOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • TAOP
  • Stock Information
  • Founded
  • QLGN 1996
  • TAOP 1993
  • Country
  • QLGN United States
  • TAOP China
  • Employees
  • QLGN N/A
  • TAOP N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • TAOP Computer Software: Prepackaged Software
  • Sector
  • QLGN Health Care
  • TAOP Technology
  • Exchange
  • QLGN Nasdaq
  • TAOP Nasdaq
  • Market Cap
  • QLGN 2.8M
  • TAOP 2.7M
  • IPO Year
  • QLGN N/A
  • TAOP N/A
  • Fundamental
  • Price
  • QLGN $3.75
  • TAOP $7.07
  • Analyst Decision
  • QLGN
  • TAOP
  • Analyst Count
  • QLGN 0
  • TAOP 0
  • Target Price
  • QLGN N/A
  • TAOP N/A
  • AVG Volume (30 Days)
  • QLGN 10.5K
  • TAOP 1.6M
  • Earning Date
  • QLGN 07-01-2025
  • TAOP 06-17-2025
  • Dividend Yield
  • QLGN N/A
  • TAOP N/A
  • EPS Growth
  • QLGN N/A
  • TAOP N/A
  • EPS
  • QLGN N/A
  • TAOP N/A
  • Revenue
  • QLGN N/A
  • TAOP $36,672,512.00
  • Revenue This Year
  • QLGN N/A
  • TAOP N/A
  • Revenue Next Year
  • QLGN N/A
  • TAOP N/A
  • P/E Ratio
  • QLGN N/A
  • TAOP N/A
  • Revenue Growth
  • QLGN N/A
  • TAOP N/A
  • 52 Week Low
  • QLGN $2.85
  • TAOP $4.26
  • 52 Week High
  • QLGN $29.44
  • TAOP $29.40
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 51.20
  • TAOP 47.66
  • Support Level
  • QLGN $3.65
  • TAOP $6.80
  • Resistance Level
  • QLGN $3.98
  • TAOP $7.98
  • Average True Range (ATR)
  • QLGN 0.14
  • TAOP 1.03
  • MACD
  • QLGN -0.01
  • TAOP -0.11
  • Stochastic Oscillator
  • QLGN 51.32
  • TAOP 34.05

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About TAOP Taoping Inc.

Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.

Share on Social Networks: